J3M-MC-JZQB
10+
Okudawunilodiwe
Wonke umuntu
info
Mayelana nalolu hlelo lokusebenza
Ucwaningo Lwe-Multicenter, Randomized, Phase 3 Study oluqhathanisa i-LY3537982 ne-Pembrolizumab ne-Placebo kanye ne-Pembrolizumab Njengokwelashwa Komugqa Wokuqala Ezigulini ezine-KRAS G12C-Mutant, Umdlavuza Wasendaweni Othuthukile noma we-Metastatic Non-Small Non-Small Cell Lung with High PD-L0 ≥TPS Expression ). Lolu hlelo lokusebenza luhloselwe abahlanganyeli ocwaningweni lwe-J3M-MC-JZQB kuphela.
Kubuyekezwe ngo-
Ukuphepha kuqala ngokuqonda ukuthi onjiniyela baqoqa futhi babelane kanjani ngedatha yakho. Ubumfihlo bedatha nezinqubo zokuphepha zingahluka kuye ngokusebenzisa kwakho, isifunda, nobudala. Unjiniyela unikeze lolu lwazi futhi angalubuyekeza ngokuhamba kwesikhathi.
Ayikho idatha eyabiwe nezinkampani zangaphandle
Funda kabanzi mayelana nendlela onjiniyela abaveza ngayo ukwabelana
Ayikho idatha eqoqiwe
Funda kabanzi mayelana nokuthi onjiniyela bakuveza kanjani ukuqoqwa
Idatha ibetheliwe lapho ithunyelwa
Yini entsha
Bug fixes and performance improvements.
Ukusekelwa kwe-app
Mayelana nonjiniyela
Medable Inc.
tim@medable.com
525 University Ave Ste A70
Palo Alto, CA 94301
United States
+1 650-231-5478
